![Pharma Market Access Insights - from Mtech Access artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/ee/4f/b6/ee4fb6d7-48d0-93d8-2836-cebc43420375/mza_14386723181000194589.jpg/100x100bb.jpg)
What's happening with specialised commissioning in the NHS?
Pharma Market Access Insights - from Mtech Access
English - February 12, 2024 16:00 - 1 hour - 41.3 MBLife Sciences Science Business pharmaceutical pharma market access health economics heor medtech nhs healthcare Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
What’s happening with specialised commissioning in the NHS? How likely is a delay in delegation to integrated care boards (ICBs)? How and what should Pharma and Medtech plan for amidst all this uncertainty?
Malcolm Qualie (former Medicines Lead for Specialised Services, NHS England) speaks to David Thorne (Principal Associate, Mtech Access) to explore specialised commissioning in the NHS and what to expect as we head into 2024.
Malcolm Qualie and David Thorne explored:
Learn more at https://mtechaccess.co.uk/nhs-specialised-commissioning/
This episode first broadcast as a live webinar in Decmeber 2023.
Subscribe to our newsletter to hear more news, insights and events from Mtech Access.